Results 61 to 70 of about 14,147 (202)

In vitro and in vivo evaluation of cephalosporins for the treatment of Lyme disease. [PDF]

open access: yes, 2018
BackgroundLyme disease accounts for >90% of all vector-borne disease cases in the United States and affect ~300,000 persons annually in North America.
Ambati, Aditya   +9 more
core  

Prevalence and Identification of Livestock Tick by Sex Ratio and Host in Tehran Province

open access: yesVeterinary Medicine and Science, Volume 11, Issue 6, November 2025.
This study identified tick species infesting livestock and poultry in Tehran Province, revealing a female‐biased sex ratio and sheep as the most infested hosts. Rhipicephalus sanguineus sensu lato was the dominant species. These findings underscore the need for host‐targeted tick control to mitigate disease transmission and economic losses.
Ebrahim Abbasi
wiley   +1 more source

Current guidelines for the management of Lyme borreliosis in European countries

open access: yesJournal of Education, Health and Sport
Introduction and purpose: Lyme borreliosis, caused by Borrelia burgdorferi sensu lato complex, is the most common vector-borne disease in Europe. Transmitted by Ixodes ticks, its prevalence is increasing due to climate change, expanded tick habitats,
Zuzanna Wyleciał   +2 more
doaj   +1 more source

Case of Lyme borreliosis in a child

open access: yesAktualʹnaâ Infektologiâ, 2019
Lyme borreliosis (synonym: Lyme disease) is an infectious transmissible natural focal disease, the causative agents of which are spirochetes, and carriers — ixodid ticks. The first cases of Lyme borreliosis in Ukraine are known since 1994.
T.M. Kosovska, V.O. Kosovska
doaj   +1 more source

Retrospective In Silico Analysis of Routine Laboratory Data Supports a Specific Association of Epstein–Barr Virus and Multiple Sclerosis

open access: yesEuropean Journal of Neurology, Volume 32, Issue 11, November 2025.
To study the association of Epstein–Barr virus (EBV) and multiple sclerosis (MS) as compared to 10 different control diseases, 10,669 patients with MS and 42,222 controls were identified by ICD10 codes and their available antiviral serologies retrieved from the hospital information system.
Mario Rodomonti   +11 more
wiley   +1 more source

Lyme’i tõve nüüdisaegne diagnostika ja ravi [PDF]

open access: yes, 2012
Puukborrelioos ehk Lyme’i tõbi (LB) on puukide edasiantav infektsioon, mille tekitajaks on Borrelia burgdorferi. Viimastel aastatel on LB-haigestumus Eestis oluliselt kasvanud.
Lutsar, Irja   +2 more
core   +2 more sources

Rapid Northward Expansion of the Blacklegged Tick, Ixodes scapularis, in Response to Climate Change

open access: yesGlobal Change Biology, Volume 31, Issue 11, November 2025.
The blacklegged tick, Ixodes scapularis, can transmit human diseases such as Lyme disease and is exposing new human populations to this risk due to its rapid expansion into Canada. We used community science data (eTick and iNaturalist) to understand the environmental factors responsible for the distribution of I.
Jacob R. Westcott   +3 more
wiley   +1 more source

Can interventions that aim to decrease Lyme disease hazard at non-domestic sites be effective without negatively affecting ecosystem health? A systematic review protocol [PDF]

open access: yes, 2016
Background Lyme disease (LD) is the most commonly reported, broadly distributed vector-borne disease of the northern temperate zone. It is transmitted by ticks and, if untreated, can cause skin, cardiac, nervous system and musculoskeletal disease.
A Caffyn   +52 more
core   +2 more sources

Lyme borreliosis and skin

open access: yesIndian Journal of Dermatology, 2013
Lyme disease is a multisystem illness which is caused by the strains of spirochete Borrelia burgdorferi sensu lato and transmitted by the tick, Ixodes. Though very commonly reported from the temperate regions of the world, the incidence has increased worldwide due to increasing travel and changing habitats of the vector.
Biju Vasudevan, Manas Chatterjee
openaire   +3 more sources

Successful Treatment of Facial Pseudolymphoma With Intravenous Rituximab: A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Intravenous rituximab demonstrated significant efficacy in treating a case of refractory cutaneous pseudolymphoma that failed multiple conventional therapies, including corticosteroids, hydroxychloroquine, methotrexate, and biologics. The patient, a 42‐year‐old man, initially developed erythematous, nodular lesions on the face following dental
Elham Behrangi   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy